A 2 min test to detect COVID-19 being commercialised in Australia

28 March 2020 by IdeaSpies

COVID-19

Congratulations to Maria Halasz and her team at Cellmid (CDY.AX) for her fantastic work on being the first to commercialise a test to detect Covid-19 within 15 minutes in Australia.

The test is available immediately and is suitable as a bedside test, can be used in hospitals, nursing homes, schools, remote areas and by corporates when administered by healthcare professionals as well as in pathology labs.

“Learning from countries that managed the coronavirus infections well it is clear that widespread COVID-19 testing, isolation of those testing positive and early treatment are the best methods to control the spread of infection, while saving lives and medical resources” said Cellmid CEO Maria Halasz. “We are excited to be able to contribute to Australia’s comprehensive effort to manage this pandemic” she added.

https://www.asx.com.au/asxpdf/20200327/pdf/44ggr9dqp991pp.pdf

What do you think?

You must be logged in to post a comment.

Comments

IdeaSpies @ 2020.03.28 8:15 PM
Wonderful development that can give us all hope that we can get through this soon.

IdeaSpies @ 2020.03.28 9:37 PM

Monitoring the spread is the only way to limit the transmitton and develop effective control strategies. Test kits need to be made freely available for every person ASAP. Those walking around us without any symptoms must be identified ASAP.

lynnwood @ 2020.03.29 3:59 AM

This is a serology test for antibodies - e.g. to test if people have had the virus so that they can be redeployed to work or safe for exposure. It is developed in China and CellMid has secured a supply agreement.

IdeaSpies @ 2020.03.29 4:00 AM

This link looks helpful.

https://www.healthline.com/health/serology

IdeaSpies @ 2020.04.10 1:58 PM
https://www.fastcompany.com/90487636/covid-19-antibody-tests-are-here-but-can-you-trust-them?

Related Posts

COVID-19

siRNA for Treatment of SARS-CoV-2

RNA interference in animals involves small double-stranded RNA molecules called siRNA. These molecules are valuable tools for studying single gene function in both in vivo and in vitro settings and are also considered a promising class of therapeutics. SiRNA delivery systems fall into two categories: viral and non-viral, including peptides, polymers, and lipids. Studies using synthetic or plasmid-encoded siRNA show its antiviral effects against various viruses, including SARS-CoV. Learn more about siRNA for Treatment of SARS-CoV-2: https://sars-cov-2.creative-biolabs.com/sirna-for-the-treatment-of-sars-cov2.htm

27 September 2023 by Creative Biol... 0 Comments

COVID-19

Vaccine factories in shipping containers

BioNTech, which co-developed a revolutionary mRNA covid-19 vaccine in partnership with Pfizer, hopes to revolutionise another area of pharmaceuticals: vaccine manufacturing. It is developing vaccine factories to sit inside a series of standard metal shipping containers, which it plans to send to parts of the world that lack their own vaccine-manufacturing capabilities-notably Africa. Each facility, BioNTech says, will be able to produce up to 60m doses of covid vaccines and other vaccines each year, and will cost "significantly less" than conventional factories. If so, this could be the future of drugmaking. https://www.economist.com/science-and-technology/biontech-plans-to-make-vaccines-in-shipping-containers/

18 February 2022 by IdeaSpies 0 Comments